Kathleen O'Brien & Cassandra Jackson
Kathy is an Associate Director of Business and Technical Analysis at Merck & Co., Inc. in West Point, PA. Kathy has over 18 years of experience in information technology, with 13 years of concentration in business analysis in industries such as defense, financial, power, and pharmaceutical. In her current role, she leads requirements development and management efforts for various key initiatives in the Global Human Health IT organization, which supports sales and marketing functions. She is also an earnest contributor to various business analyst communities at Merck, including the Analysis Skills Center, which is a Center of Excellence for business analysis standards and best practices. Kathy is an active member of the Greater Philadelphia Chapter of the IIBA and is currently serving on the board as the chapter secretary.
Cassandra is a Lead Business Analyst at Pfizer Incorporated. Cassandra has worked for more than twenty years as a business analyst supporting Fortune 100 pharmaceutical and technology companies. She combines her passion for analysis and collaboration to identify digital solutions to address business outcomes for a range of stakeholders. As some of her proudest accomplishments, she led requirements development and management efforts in support of Pfizer’s Expanded Access global implementation in a number of countries and participated in one of the first de-centralized clinical trials conducted by Pfizer. She enjoys coaching others in the discipline of business analysis throughout the organizations she has worked.